Biosimilars Boosted By Australian Initiatives
Market Share Close To A Quarter Following Educational Efforts
Australia has reaped the rewards of outreach efforts on biosimilars, according to the country’s GBMA off-patent industry association, with the market share enjoyed by biosimilar medicines rising significantly in the two years since Australia’s government issued a grant for educational activities. In future, the GBMA’s Biosimilar Awareness Week could be used as the model for a global biosimilars campaign backed by the IGBA.
You may also be interested in...
A series of educational events and messages are being rolled out by Australia’s GBMA industry association as part of “Biosimilar Awareness Week.”
Australia’s GBMA is rolling out its second annual “Biosimilar Week” later this month as part of a three-year education program being pursued by the association and industry stakeholders.
A ‘biosimilar education grant’ of A$5 million (US$3.8 million) has been awarded by Australia’s government to the country’s Generic and Biosimilar Medicines Association (GBMA) to “complement and extend” activities being undertaken as part of the country’s biosimilar awareness initiative.